Please assess the completion status of the following clinical trial:

Trial Title: MI Varnish and MI Paste Plus in a Caries Prevention and Remineralization Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age 11 or older,~* good health,~* either gender~* present with at least two active white spot lesions on his/her anterior teeth at the start of the study~* have a moderate or high caries risk according to CAMBRA (Caries Management By Risk Assessment) rules~* require at least 12 additional months of full fixed appliance therapy from the time they are recruited for the study~* able to cooperate for treatment in the dental chair and follow at-home instructions~* have an understanding of the study~* willing to comply with all study procedures and protocols~* patient participant is able to provide written informed consent in English; if the participant is a minor, the parent/guardian is able to provide written informed consent in English and the patient participant is able to provide written assent in English~* patient participant or if a minor, the parent/guardian, is willing to sign the Authorization for Release of Personal Health Information and Use of Personally Unidentified Study Data for Research form; data will only be used for research~* verifiable records of bonding with Transbond Plus Self-Etching Primer (3M Unitek, Monrovia, CA) and Transbond Light Cure Adhesive or similar products~* verifiable records that ProSeal has not been applied at any time during the orthodontic treatment~Exclusion Criteria:~* untreated cavitated lesions~* extensive composite fillings on buccal surfaces of front teeth/first bicuspids or more than one dental crown on front teeth/first bicuspids~* has sealants or fluoride releasing cements on the buccal surface of the anterior teeth~* in-office fluoride treatment in the last three months~* history of using any products containing CCP-ACP (casein phosphopeptides and amorphous calcium phosphate; MI paste, chewing gums or candies, etc.), prescription Fluoride products, and Chlorhexidine use in the last three months~* intrinsic or extremely heavy extrinsic staining~* any signs of fluorosis in the dentition~* any signs of morphologic/anatomical/developmental deviations in the teeth~* previous history of in office bleaching treatment~* subject not willing to stop the use of any other oral hygiene product than those prescribed/suggested~* has underlying systemic disease which could alter enamel composition or formation~* suffering from systemic diseases, significant past or medical history with conditions that may affect oral health or oral flora (i.e. diabetes, HIV, heart conditions that require antibiotic prophylaxis)~* use of medication causing dry mouth (extreme high caries risk)~* subject is pregnant or lactating~* milk protein allergy~* any illness/condition that the investigator feels will affect the study outcome~* will leave the area and will not be available for recall visits~* subjects who are not willing to inform us about prospective visits of other dentist and will not allow us to discuss treatment with those dentist~* subjects who are not willing to refrain from any additional professional tooth cleaning or any additional Fluoride application.

- Gender: ALL
- Minimum Age: 11 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- MI Paste & MI Varnish (Type: EXPERIMENTAL): MI past will be applied by the patient every night; MI varnish will be applied every three months in the office
- Standard of Care (Type: ACTIVE_COMPARATOR): Subjects will use at home regal toothpaste every night and F-mouth rinse as recommended

Based on this trial design, predict the completion outcome and termination type (if applicable).